Leidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says

MT Newswires Live06-17 22:54

Leidos' (LDOS) healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.

BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.

It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.

The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.

BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.

Price: 110.13, Change: -3.45, Percent Change: -3.04

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Comments

We need your insight to fill this gap

Leave a comment

{"i18n":{"language":"en_US"},"isChannel":false,"data":{"share":"https://ttm.financial/m/news/2644742103?lang=en_US&edition=fundamental","thumbnail":"","is_english":true,"pubTime":"2026-06-17 22:54","share_image_url":"https://static.laohu8.com/e9f99090a1c2ed51c021029395664489","id":"2644742103","market":"hk","top_or_hot":-1,"title":"Leidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says","media":"MT Newswires Live","content":"<html><body><p> Leidos' (LDOS) healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.</p><p>BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.</p><p>It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.</p><p>The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.</p><p>BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.</p><p>Price: 110.13, Change: -3.45, Percent Change: -3.04</p></body></html>","source":"mtnewswires_news","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>Leidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\nLeidos' Healthcare Business Sees Limited Future Upside From Increasing Competition, BofA Securities Says\n</h2>\n\n<h4 class=\"meta\">\n\n\n<a class=\"head\" href=\"https://laohu8.com/wemedia/1092851196\">\n\n\n<div class=\"h-thumb\" style=\"background-image:url(https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e);background-size:cover;\"></div>\n\n<div class=\"h-content\">\n<p class=\"h-name\">MT Newswires Live </p>\n<p class=\"h-time\">2026-06-17 22:54</p>\n</div>\n\n</a>\n\n\n</h4>\n\n</header>\n<article>\n<html><body><p> Leidos' (LDOS) healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.</p><p>BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.</p><p>It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.</p><p>The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.</p><p>BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.</p><p>Price: 110.13, Change: -3.45, Percent Change: -3.04</p></body></html>\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"XLV","symbol_name":"健康照护类股ETF-SPDR","start_time":0,"source_url":"https://www.mtnewswires.com/","article_id":"2644742103","we_media_id":"1092851196","thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2644742103","pubTimestamp":1781708063,"columns":[],"sourceInfo":{"source_id":"mtnewswires_news","name":"MT Newswires"},"weMediaInfo":{"media_name":"MT Newswires Live","introduction":"The most recognized names in North America, Europe and Asia rely on MT Newswires to power their applications. Better news, better service, better price.","home_visible":1,"id":"1092851196","head_image":"https://community-static.tradeup.com/news/3002d84abbd5ace3c99397c7f95b8d4e"},"summary":"Leidos'  healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.Price: 110.13, Change: -3.45, Percent Change: -3.04","collect":0,"end_time":0,"defaultTopTitle":"","property":[],"viewcount":null,"language":"en","relate_stocks":{"XLV":"健康照护类股ETF-SPDR","LDOS":"Leidos Holdings Inc","LABU":"三倍做多标普生物-Direxion","BK4137":"综合支持服务","BK4588":"碎股","HCSG":"Healthcare Svcs Group Inc","BK4585":"ETF&股票定投概念","BK4123":"调查和咨询服务","BK4581":"高盛持仓","XBI":"SPDR S&P Biotech ETF","LU0128526141.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" ACC","LU0029874061.USD":"TEMPLETON GLOBAL SMALLER COMPANIES \"A\" YDIS INC","LU0006061336.USD":"Blackrock US Small and MidCap Opportunities A2 USD"},"translate_title":"美国银行证券表示，Leidos的医疗保健业务未来因竞争加剧而上涨空间有限","themeId":"f6f7c9f6a0174df79daf9f1dfd21f836","isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"LABU":0.6,"XLV":1.5,"LDOS":1.5,"HCSG":1.5,"XBI":0.6},"content_text":"Leidos' (LDOS) healthcare business sees limited future upside from increasing competition, BofA Securities said in a Wednesday note.BofA said it sees near-term pressure on the healthcare business as the U.S. Defense Health Agency seeks to work directly with suppliers in the Defense Health Management System Modernization program's maintenance phase.It also said the upcoming Medical Disability Examinations recompete could weigh on Leidos' future share and pricing power.The investment banking firm said it continues to recognize the value of Leidos' defense portfolio, but added that it does not believe investors will give credit for full value of the opportunities until the results begin to materialize.BofA downgraded Leidos to neutral from buy and adjusted its price target to $125 from $200.Price: 110.13, Change: -3.45, Percent Change: -3.04","kind":"highlight","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"-1","news_tag":"","news_rank":0,"isVideo":false,"video":null,"symbols":[],"gpt_button":0,"need_auth":false,"need_login_tip":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":true,"isLaohu8Offline":false,"tenantId":"TBGLOBAL","deviceId":"web-server-community-laohu8-v3","version":"4.44.0","shortVersion":"4.44.0","platform":"web","vendor":"web","appName":"ttm","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2644742103","isCrawlerRequest":true}